PL408727A1 - Diagnostic set and method for simultaneous detection of mutations within the NF1 gene for the group of patients with suspected Recklinghausen disease
- Google Patents
Diagnostic set and method for simultaneous detection of mutations within the NF1 gene for the group of patients with suspected Recklinghausen disease
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genomed Spółka AkcyjnafiledCriticalGenomed Spółka Akcyjna
Priority to PL408727ApriorityCriticalpatent/PL227811B1/en
Publication of PL408727A1publicationCriticalpatent/PL408727A1/en
Publication of PL227811B1publicationCriticalpatent/PL227811B1/en
Measuring Or Testing Involving Enzymes Or Micro-Organisms
(AREA)
Abstract
Przedmiotem wynalazku jest zestaw diagnostyczny, zawierający określoną pulę grup primerów oraz sposób wykrywania mutacji w obrębie genu NF1 u pacjentów z podejrzeniem choroby Recklinghausena. The subject of the invention is a diagnostic kit containing a specific pool of primer groups and a method of detecting mutations within the NF1 gene in patients with suspected Recklinghausen disease.
PL408727A2014-06-302014-06-30Diagnostic set and method for simultaneous detection of mutations within the NF1 gene for the group of patients with suspected Recklinghausen disease
PL227811B1
(en)
igfbp3 inhibitor, pharmaceutical composition for use in the treatment and / or prevention of an intestinal disorder, method for the diagnosis of an intestinal disorder in an individual and kit for the diagnosis of an intestinal disorder
antibodies, nucleic acid, host cell, antibody production method, immunoconjugate, pharmaceutical formulation, methods of detecting human lgr5 in a biological sample, detecting a cancer, identifying a cancer patient, selecting a patient with cancer for treatment with an immunoconjugate and treatment of a cancer patient
Method for detecting cardiac failure patient, method for discrimination of cardiac disease, test reagent for cardiac failure, test kit for cardiac failure, device for detecting cardiac failure, and program for detecting cardiac failure